JHIU
PDSB icon

Janus Henderson Investors US’s PDS Biotechnology PDSB Stock Holding History

Janus Henderson Investors US’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$19.3M Sell
105,778
-2,398
-2% -$475K 0.02% 614
2016
Q4 		$27M Sell
108,176
-5,685
-5% -$1.29M 0.02% 565
2016
Q3 		$23.7M Sell
113,861
-2,866
-2% -$568K 0.02% 560
2016
Q2 		$23.6M Buy
116,727
+80,965
+226% +$14.3M 0.02% 547
2016
Q1 		$6.55M Buy
35,762
+362
+1% +$64.7K 0.01% 730
2015
Q4 		$8.85M Buy
+35,400
New +$11.4M 0.01% 730

Other funds holding PDSB

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Investors US's PDSB Position: Q1 2017 in Review

Janus Henderson Investors US reduced its PDS Biotechnology (PDSB) stake by 2.2% in Q1 2017, selling an estimated $475K and leaving 105,778 shares worth $19.3M. The position accounts for 0.02% of the portfolio, ranked #614.

Janus Henderson Investors US first reported a position in PDSB in Q4 2015 and has held it in 6 quarters since. The position peaked at $27M in Q4 2016. 52 funds tracked by Wall St. Rank hold PDSB as of Q1 2017.

  • Janus Henderson Investors US held 105,778 shares of PDS Biotechnology worth $19.3M as of Q1 2017.
  • Janus Henderson Investors US sold 2,398 PDS Biotechnology shares in Q1 2017, an estimated $475K.
  • PDS Biotechnology made up 0.02% of Janus Henderson Investors US's portfolio in Q1 2017, its #614 holding.
  • Janus Henderson Investors US first reported a position in PDS Biotechnology in Q4 2015 and has held it in 6 quarters since.
  • Janus Henderson Investors US's PDS Biotechnology position peaked at $27M in Q4 2016.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.